Literature DB >> 12403279

Who remains undelivered more than seven days after a single course of prenatal corticosteroids and gives birth at less than 34 weeks?

K J McLaughlin1, C A Crowther, P Vigneswaran, E Hancock, K Willson.   

Abstract

UNLABELLED: Minimal information exists as to how women who give birth more than seven days after initial corticosteroid treatment, who may benefit from repeat prenatal corticosteroids, differ from women who give birth within seven days, at < 34 weeks gestation.
OBJECTIVES: To examine the differences, if any, between women who received a single course of prenatal corticosteroids and remained undelivered more than seven days later and women who gave birth within seven days of treatment, at < 34 weeks gestation.
DESIGN: Retrospective cohort.
SETTING: Women's and Children's Hospital, Adelaide. POPULATION: Women who gave birth at < 34 weeks gestation from 1 January 1994 to 31 December 1996.
METHODS: Data were extracted from medical records and retrieved from the hospital's database. MAIN POTENTIAL PREDICTORS COLLECTED: Prenatal corticosteroid exposure, reason for risk of preterm birth, maternal demographics and previous and current obstetric history.
RESULTS: Of the 506 women, 122 (24%) remained undelivered more than seven days following prenatal corticosteroid therapy Initial corticosteroid treatment was given on average 1.6 weeks earlier to women who remained undelivered more than seven days after treatment. Women who were given prenatal corticosteroids for placenta praevia (RR 6.03, 95% CI 2.67-13.61, p < 0.01) or cervical incompetence (RR 3.40, 95% CI 1.06-10.95, p = 0.04) were more likely to give birth more than seven days after corticosteroid treatment.
CONCLUSIONS: Women who give birth very preterm, who remain undelivered more than seven days after prenatal corticosteroids, differ in the reasons for and timing of their first course from women who give birth within seven days.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12403279     DOI: 10.1111/j.0004-8666.2002.00353.x

Source DB:  PubMed          Journal:  Aust N Z J Obstet Gynaecol        ISSN: 0004-8666            Impact factor:   2.100


  6 in total

Review 1.  Antenatal corticosteroids in the management of preterm birth: are we back where we started?

Authors:  Clarissa Bonanno; Ronald J Wapner
Journal:  Obstet Gynecol Clin North Am       Date:  2012-03       Impact factor: 2.844

Review 2.  Controversy: antenatal steroids.

Authors:  Ronald Wapner; Alan H Jobe
Journal:  Clin Perinatol       Date:  2011-09       Impact factor: 3.430

3.  The role of progesterone in prevention of preterm birth.

Authors:  Jodie M Dodd; Caroline A Crowther
Journal:  Int J Womens Health       Date:  2010-08-09

4.  Antenatal Betamethasone: A Prolonged Time Interval from Administration to Delivery Is Associated with an Increased Incidence of Severe Intraventricular Hemorrhage in Infants Born before 28 Weeks Gestation.

Authors:  Melissa Liebowitz; Ronald I Clyman
Journal:  J Pediatr       Date:  2016-08-08       Impact factor: 4.406

5.  Progesterone after previous preterm birth for prevention of neonatal respiratory distress syndrome (PROGRESS): a randomised controlled trial.

Authors:  Jodie M Dodd; Caroline A Crowther; Andrew J McPhee; Vicki Flenady; Jeffrey S Robinson
Journal:  BMC Pregnancy Childbirth       Date:  2009-02-24       Impact factor: 3.007

6.  Repeat prenatal corticosteroid prior to preterm birth: a systematic review and individual participant data meta-analysis for the PRECISE study group (prenatal repeat corticosteroid international IPD study group: assessing the effects using the best level of evidence) - study protocol.

Authors:  Caroline A Crowther; Fariba Aghajafari; Lisa M Askie; Elizabeth V Asztalos; Peter Brocklehurst; Tanya K Bubner; Lex W Doyle; Sourabh Dutta; Thomas J Garite; Debra A Guinn; Mikko Hallman; Mary E Hannah; Pollyanna Hardy; Kimberly Maurel; Premasish Mazumder; Cindy McEvoy; Philippa F Middleton; Kellie E Murphy; Outi M Peltoniemi; Dawn Peters; Lisa Sullivan; Elizabeth A Thom; Merryn Voysey; Ronald J Wapner; Lisa Yelland; Sasha Zhang
Journal:  Syst Rev       Date:  2012-02-12
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.